Nivolumab superior to ipilimumab for adjuvant treatment of melanoma
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma...
List view / Grid view
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma...
According to results of the LORELEI clinical trial, adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer...
Pembrolizumab has shown a promising response rate in patients with pre-treated metastatic gastric cancer, according to results from the KEYNOTE-059 trial...
Researchers have found that asthma medicine can halve a patient's risk of developing Parkinson's disease...
A team of researchers have found that a common heart disease medication may help treat lung disease...
The FDA has approved CAR T cell therapy for treatment of children with acute lymphoblastic leukemia...
Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer...
Researchers have recently discovered an immunotherapy that uses existing cancer drugs in a whole new way...
An international clinical trial has assessed the efficacy and safety of adding anacetrapib versus placebo atorvastatin in patients with vascular diseases...
Brazilian researchers have investigated whether cisplatin and 5-FU would interfere with the protein pRB...
A team of scientists have recently discovered how a new drug called JQ1 which is currently in early-phase human cancer trials, can reactivate latent HIV...
Scientists have developed a method to efficiently modify natural antibodies that can deliver drugs to target cells...
Researchers have connected docosahexaenoic (DHA) synthesis to oestrogen production and consequentially brain health...
Scientists have made progress in the development of products that improve mitochondrial function...
Researchers have identified a drug regimen administered prior to and after surgery that significantly reduces the risk of post-surgical cancer recurrence...